James Hathorn is an Oncology physician affiliated with The US Oncology Network. OpenAlex indexes 31 publications with 2,789 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
516 S Van Buren Rd
Eden, NC 272885019
Telephone
336-623-6862Provider last certified this registry record 10 May 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- BeiGene USA, Inc.Program year20241 payment
- BeiGene USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
28.7%Aromatase Inhibitor10.2%Anastrozole94%Letrozole6%Part D<11 patientsKinase inhibitor7%Brukinsa43%Imatinib Mesylate19%Imbruvica13%Cabometyx9%Tasigna9%Sprycel8%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
25.8%Potassium supplement8.9%Potassium Chloride83%Klor-Con M2017%Part D≥41 patientsSerotonin-3 Receptor Antagonist7.5%Ondansetron Hcl86%Ondansetron Odt14%Part D≥84 patients+ 5 more classes in this area
Nervous system
22.2%Opioid Agonist9.2%Oxycodone-Acetaminophen39%Oxycodone Hcl24%Fentanyl23%Tramadol Hcl13%Part D≥27 patientsPhenothiazine7.4%Prochlorperazine Maleate100%Part D≥93 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of the radiation dose exposure and associated cancer risks in patients having preoperative parathyroid localization
Annals of The Royal College of Surgeons of England
2017 - A Novel Fasting Blood Test for Insulin Resistance and Prediabetes
Journal of Diabetes Science and Technology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Paulson, MD
The US Oncology Network
Vicky E. Jones
The US Oncology Network
Rama Balaraman, MD
The US Oncology Network
Philip Dien, MD
The US Oncology Network
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”